For example, Tadayon et al. reported the correlations between ChP volume and CSF biomarkers of amyloid-β42 (Aβ42), total tau (t-tau), and phosphorylated tau (p-tau) in AD patients [6]. Here, MAPT is linked to Alzheimer disease.